nodes	percent_of_prediction	percent_of_DWPC	metapath
Maraviroc—CYP3A4—Chenodeoxycholic acid—primary biliary cirrhosis	0.255	0.664	CbGbCtD
Maraviroc—CYP3A4—Colchicine—primary biliary cirrhosis	0.129	0.336	CbGbCtD
Maraviroc—CCR5—IL12-mediated signaling events—IL12RB2—primary biliary cirrhosis	0.0287	0.117	CbGpPWpGaD
Maraviroc—Hepatic cirrhosis—Chenodeoxycholic acid—primary biliary cirrhosis	0.0151	0.0408	CcSEcCtD
Maraviroc—Hepatic cirrhosis—Ursodeoxycholic acid—primary biliary cirrhosis	0.0151	0.0408	CcSEcCtD
Maraviroc—CCR5—IL12-mediated signaling events—CD3D—primary biliary cirrhosis	0.0122	0.0495	CbGpPWpGaD
Maraviroc—CCR5—Chemokine receptors bind chemokines—CXCR5—primary biliary cirrhosis	0.0116	0.0472	CbGpPWpGaD
Maraviroc—CCR5—Chemokine receptors bind chemokines—CXCL9—primary biliary cirrhosis	0.0106	0.0429	CbGpPWpGaD
Maraviroc—CCR5—IL12-mediated signaling events—IL12A—primary biliary cirrhosis	0.00972	0.0395	CbGpPWpGaD
Maraviroc—CCR5—Peptide GPCRs—CXCR5—primary biliary cirrhosis	0.0093	0.0378	CbGpPWpGaD
Maraviroc—CCR5—TCR Signaling Pathway—CD3D—primary biliary cirrhosis	0.00882	0.0358	CbGpPWpGaD
Maraviroc—CYP3A4—Drug Induction of Bile Acid Pathway—SLC51B—primary biliary cirrhosis	0.00774	0.0314	CbGpPWpGaD
Maraviroc—CCR5—TCR Signaling Pathway—MAP3K14—primary biliary cirrhosis	0.00768	0.0312	CbGpPWpGaD
Maraviroc—CCR5—IL12-mediated signaling events—STAT4—primary biliary cirrhosis	0.00667	0.0271	CbGpPWpGaD
Maraviroc—Creatine phosphokinase increased—Colchicine—primary biliary cirrhosis	0.00613	0.0166	CcSEcCtD
Maraviroc—CCR5—IL12-mediated signaling events—IL12B—primary biliary cirrhosis	0.0061	0.0248	CbGpPWpGaD
Maraviroc—CYP3A4—Drug Induction of Bile Acid Pathway—SLC51A—primary biliary cirrhosis	0.00587	0.0238	CbGpPWpGaD
Maraviroc—CCR5—Chemokine receptors bind chemokines—CXCL10—primary biliary cirrhosis	0.0055	0.0223	CbGpPWpGaD
Maraviroc—CCR5—GPCRs, Class A Rhodopsin-like—MAS1—primary biliary cirrhosis	0.00513	0.0208	CbGpPWpGaD
Maraviroc—Polyp—Chenodeoxycholic acid—primary biliary cirrhosis	0.00476	0.0129	CcSEcCtD
Maraviroc—Transaminases increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00476	0.0129	CcSEcCtD
Maraviroc—Polyp—Ursodeoxycholic acid—primary biliary cirrhosis	0.00476	0.0129	CcSEcCtD
Maraviroc—Transaminases increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00476	0.0129	CcSEcCtD
Maraviroc—CCR5—Chemokine receptors bind chemokines—CCL5—primary biliary cirrhosis	0.00473	0.0192	CbGpPWpGaD
Maraviroc—Blood creatine phosphokinase increased—Colchicine—primary biliary cirrhosis	0.00468	0.0127	CcSEcCtD
Maraviroc—CCR5—Peptide ligand-binding receptors—CXCR5—primary biliary cirrhosis	0.00438	0.0178	CbGpPWpGaD
Maraviroc—CCR5—IL12-mediated signaling events—IL4—primary biliary cirrhosis	0.00434	0.0176	CbGpPWpGaD
Maraviroc—Cyst—Chenodeoxycholic acid—primary biliary cirrhosis	0.00433	0.0117	CcSEcCtD
Maraviroc—Cyst—Ursodeoxycholic acid—primary biliary cirrhosis	0.00433	0.0117	CcSEcCtD
Maraviroc—Neuritis—Colchicine—primary biliary cirrhosis	0.00432	0.0117	CcSEcCtD
Maraviroc—CCR5—HIV Life Cycle—NUP210—primary biliary cirrhosis	0.00412	0.0167	CbGpPWpGaD
Maraviroc—CCR5—Peptide ligand-binding receptors—CXCL9—primary biliary cirrhosis	0.00397	0.0161	CbGpPWpGaD
Maraviroc—Otitis media—Chenodeoxycholic acid—primary biliary cirrhosis	0.00372	0.0101	CcSEcCtD
Maraviroc—Otitis media—Ursodeoxycholic acid—primary biliary cirrhosis	0.00372	0.0101	CcSEcCtD
Maraviroc—CCR5—G alpha (i) signalling events—CXCR5—primary biliary cirrhosis	0.00369	0.015	CbGpPWpGaD
Maraviroc—Rhabdomyolysis—Colchicine—primary biliary cirrhosis	0.00364	0.00984	CcSEcCtD
Maraviroc—Gamma-glutamyltransferase increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00352	0.00951	CcSEcCtD
Maraviroc—Gamma-glutamyltransferase increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00352	0.00951	CcSEcCtD
Maraviroc—Oliguria—Colchicine—primary biliary cirrhosis	0.0035	0.00945	CcSEcCtD
Maraviroc—Acne—Chenodeoxycholic acid—primary biliary cirrhosis	0.00344	0.0093	CcSEcCtD
Maraviroc—Acne—Ursodeoxycholic acid—primary biliary cirrhosis	0.00344	0.0093	CcSEcCtD
Maraviroc—CCR5—GPCRs, Class A Rhodopsin-like—CXCR5—primary biliary cirrhosis	0.00343	0.0139	CbGpPWpGaD
Maraviroc—CCR5—IL12-mediated signaling events—NOS2—primary biliary cirrhosis	0.00342	0.0139	CbGpPWpGaD
Maraviroc—CCR5—G alpha (i) signalling events—CXCL9—primary biliary cirrhosis	0.00335	0.0136	CbGpPWpGaD
Maraviroc—CCR5—HIV Infection—ELMO1—primary biliary cirrhosis	0.00332	0.0135	CbGpPWpGaD
Maraviroc—CYP3A4—Codeine and Morphine Metabolism—ABCC2—primary biliary cirrhosis	0.00324	0.0131	CbGpPWpGaD
Maraviroc—Herpes simplex—Chenodeoxycholic acid—primary biliary cirrhosis	0.00314	0.00849	CcSEcCtD
Maraviroc—Herpes simplex—Ursodeoxycholic acid—primary biliary cirrhosis	0.00314	0.00849	CcSEcCtD
Maraviroc—Cataract—Ursodeoxycholic acid—primary biliary cirrhosis	0.00304	0.00822	CcSEcCtD
Maraviroc—Cataract—Chenodeoxycholic acid—primary biliary cirrhosis	0.00304	0.00822	CcSEcCtD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—CXCR5—primary biliary cirrhosis	0.00293	0.0119	CbGpPWpGaD
Maraviroc—CCR5—HIV Infection—NUP210—primary biliary cirrhosis	0.00284	0.0115	CbGpPWpGaD
Maraviroc—Influenza like illness—Chenodeoxycholic acid—primary biliary cirrhosis	0.00281	0.0076	CcSEcCtD
Maraviroc—Influenza like illness—Ursodeoxycholic acid—primary biliary cirrhosis	0.00281	0.0076	CcSEcCtD
Maraviroc—CCR5—IL12-mediated signaling events—TYK2—primary biliary cirrhosis	0.0028	0.0114	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—CXCL9—primary biliary cirrhosis	0.00267	0.0108	CbGpPWpGaD
Maraviroc—Neoplasm—Chenodeoxycholic acid—primary biliary cirrhosis	0.00262	0.00708	CcSEcCtD
Maraviroc—Neoplasm—Ursodeoxycholic acid—primary biliary cirrhosis	0.00262	0.00708	CcSEcCtD
Maraviroc—Vascular purpura—Colchicine—primary biliary cirrhosis	0.00262	0.00707	CcSEcCtD
Maraviroc—CYP3A4—Farnesoid X Receptor  Pathway—ABCB4—primary biliary cirrhosis	0.00247	0.01	CbGpPWpGaD
Maraviroc—Lymphadenopathy—Ursodeoxycholic acid—primary biliary cirrhosis	0.00246	0.00666	CcSEcCtD
Maraviroc—Lymphadenopathy—Chenodeoxycholic acid—primary biliary cirrhosis	0.00246	0.00666	CcSEcCtD
Maraviroc—Sleep disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00243	0.00656	CcSEcCtD
Maraviroc—Sleep disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00243	0.00656	CcSEcCtD
Maraviroc—Purpura—Colchicine—primary biliary cirrhosis	0.00243	0.00656	CcSEcCtD
Maraviroc—Blood alkaline phosphatase increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00242	0.00653	CcSEcCtD
Maraviroc—Blood alkaline phosphatase increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00242	0.00653	CcSEcCtD
Maraviroc—Deafness—Chenodeoxycholic acid—primary biliary cirrhosis	0.00235	0.00635	CcSEcCtD
Maraviroc—Deafness—Ursodeoxycholic acid—primary biliary cirrhosis	0.00235	0.00635	CcSEcCtD
Maraviroc—Haemolytic anaemia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00233	0.00629	CcSEcCtD
Maraviroc—Haemolytic anaemia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00233	0.00629	CcSEcCtD
Maraviroc—Amnesia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00224	0.00605	CcSEcCtD
Maraviroc—Amnesia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00224	0.00605	CcSEcCtD
Maraviroc—CCR5—GPCR ligand binding—CXCR5—primary biliary cirrhosis	0.00223	0.00907	CbGpPWpGaD
Maraviroc—CCR5—IL12-mediated signaling events—NFKB1—primary biliary cirrhosis	0.00218	0.00886	CbGpPWpGaD
Maraviroc—Cerebrovascular accident—Chenodeoxycholic acid—primary biliary cirrhosis	0.00215	0.0058	CcSEcCtD
Maraviroc—Cerebrovascular accident—Ursodeoxycholic acid—primary biliary cirrhosis	0.00215	0.0058	CcSEcCtD
Maraviroc—Aspartate aminotransferase increased—Colchicine—primary biliary cirrhosis	0.00211	0.00569	CcSEcCtD
Maraviroc—CCR5—Peptide ligand-binding receptors—CXCL10—primary biliary cirrhosis	0.00207	0.0084	CbGpPWpGaD
Maraviroc—CYP3A4—Irinotecan Pathway—ABCC2—primary biliary cirrhosis	0.00207	0.0084	CbGpPWpGaD
Maraviroc—Alanine aminotransferase increased—Colchicine—primary biliary cirrhosis	0.00206	0.00558	CcSEcCtD
Maraviroc—CCR5—GPCR ligand binding—CXCL9—primary biliary cirrhosis	0.00203	0.00824	CbGpPWpGaD
Maraviroc—Pancytopenia—Colchicine—primary biliary cirrhosis	0.00192	0.00519	CcSEcCtD
Maraviroc—Orthostatic hypotension—Ursodeoxycholic acid—primary biliary cirrhosis	0.00192	0.00519	CcSEcCtD
Maraviroc—Abdominal pain upper—Chenodeoxycholic acid—primary biliary cirrhosis	0.00192	0.00519	CcSEcCtD
Maraviroc—Orthostatic hypotension—Chenodeoxycholic acid—primary biliary cirrhosis	0.00192	0.00519	CcSEcCtD
Maraviroc—Abdominal pain upper—Ursodeoxycholic acid—primary biliary cirrhosis	0.00192	0.00519	CcSEcCtD
Maraviroc—Breast disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.0019	0.00513	CcSEcCtD
Maraviroc—Breast disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.0019	0.00513	CcSEcCtD
Maraviroc—Aspartate aminotransferase increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00189	0.00512	CcSEcCtD
Maraviroc—Aspartate aminotransferase increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00189	0.00512	CcSEcCtD
Maraviroc—Neutropenia—Colchicine—primary biliary cirrhosis	0.00189	0.00511	CcSEcCtD
Maraviroc—Alanine aminotransferase increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00185	0.00501	CcSEcCtD
Maraviroc—Alanine aminotransferase increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00185	0.00501	CcSEcCtD
Maraviroc—Influenza—Ursodeoxycholic acid—primary biliary cirrhosis	0.00182	0.00491	CcSEcCtD
Maraviroc—Influenza—Chenodeoxycholic acid—primary biliary cirrhosis	0.00182	0.00491	CcSEcCtD
Maraviroc—Pancreatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00178	0.00481	CcSEcCtD
Maraviroc—Pancreatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00178	0.00481	CcSEcCtD
Maraviroc—CCR5—Peptide ligand-binding receptors—CCL5—primary biliary cirrhosis	0.00178	0.00723	CbGpPWpGaD
Maraviroc—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC2—primary biliary cirrhosis	0.00177	0.00719	CbGpPWpGaD
Maraviroc—Angina pectoris—Ursodeoxycholic acid—primary biliary cirrhosis	0.00177	0.00478	CcSEcCtD
Maraviroc—Angina pectoris—Chenodeoxycholic acid—primary biliary cirrhosis	0.00177	0.00478	CcSEcCtD
Maraviroc—Neuropathy peripheral—Colchicine—primary biliary cirrhosis	0.00177	0.00478	CcSEcCtD
Maraviroc—CYP3A4—Irinotecan Pathway—ABCG2—primary biliary cirrhosis	0.00176	0.00714	CbGpPWpGaD
Maraviroc—Stomatitis—Colchicine—primary biliary cirrhosis	0.00176	0.00475	CcSEcCtD
Maraviroc—Bronchitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00175	0.00472	CcSEcCtD
Maraviroc—Bronchitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00175	0.00472	CcSEcCtD
Maraviroc—CCR5—G alpha (i) signalling events—CXCL10—primary biliary cirrhosis	0.00175	0.00709	CbGpPWpGaD
Maraviroc—Upper respiratory tract infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.00169	0.00456	CcSEcCtD
Maraviroc—Upper respiratory tract infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.00169	0.00456	CcSEcCtD
Maraviroc—Agranulocytosis—Colchicine—primary biliary cirrhosis	0.00168	0.00455	CcSEcCtD
Maraviroc—Pneumonia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00163	0.0044	CcSEcCtD
Maraviroc—Pneumonia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00163	0.0044	CcSEcCtD
Maraviroc—Infestation—Chenodeoxycholic acid—primary biliary cirrhosis	0.00162	0.00438	CcSEcCtD
Maraviroc—Infestation NOS—Ursodeoxycholic acid—primary biliary cirrhosis	0.00162	0.00438	CcSEcCtD
Maraviroc—Infestation—Ursodeoxycholic acid—primary biliary cirrhosis	0.00162	0.00438	CcSEcCtD
Maraviroc—Infestation NOS—Chenodeoxycholic acid—primary biliary cirrhosis	0.00162	0.00438	CcSEcCtD
Maraviroc—Depression—Ursodeoxycholic acid—primary biliary cirrhosis	0.00162	0.00437	CcSEcCtD
Maraviroc—Depression—Chenodeoxycholic acid—primary biliary cirrhosis	0.00162	0.00437	CcSEcCtD
Maraviroc—Acute coronary syndrome—Ursodeoxycholic acid—primary biliary cirrhosis	0.0016	0.00432	CcSEcCtD
Maraviroc—Acute coronary syndrome—Chenodeoxycholic acid—primary biliary cirrhosis	0.0016	0.00432	CcSEcCtD
Maraviroc—Renal failure—Ursodeoxycholic acid—primary biliary cirrhosis	0.00159	0.0043	CcSEcCtD
Maraviroc—Renal failure—Chenodeoxycholic acid—primary biliary cirrhosis	0.00159	0.0043	CcSEcCtD
Maraviroc—Myocardial infarction—Chenodeoxycholic acid—primary biliary cirrhosis	0.00159	0.00429	CcSEcCtD
Maraviroc—Myocardial infarction—Ursodeoxycholic acid—primary biliary cirrhosis	0.00159	0.00429	CcSEcCtD
Maraviroc—Jaundice—Chenodeoxycholic acid—primary biliary cirrhosis	0.00158	0.00427	CcSEcCtD
Maraviroc—Jaundice—Ursodeoxycholic acid—primary biliary cirrhosis	0.00158	0.00427	CcSEcCtD
Maraviroc—CCR5—TCR Signaling Pathway—NFKB1—primary biliary cirrhosis	0.00158	0.00641	CbGpPWpGaD
Maraviroc—Conjunctivitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00157	0.00426	CcSEcCtD
Maraviroc—Conjunctivitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00157	0.00426	CcSEcCtD
Maraviroc—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—primary biliary cirrhosis	0.00155	0.00628	CbGpPWpGaD
Maraviroc—Hepatobiliary disease—Chenodeoxycholic acid—primary biliary cirrhosis	0.00153	0.00414	CcSEcCtD
Maraviroc—Hepatobiliary disease—Ursodeoxycholic acid—primary biliary cirrhosis	0.00153	0.00414	CcSEcCtD
Maraviroc—Sinusitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00152	0.00411	CcSEcCtD
Maraviroc—Sinusitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00152	0.00411	CcSEcCtD
Maraviroc—Eye disorder—Colchicine—primary biliary cirrhosis	0.00151	0.00409	CcSEcCtD
Maraviroc—CCR5—G alpha (i) signalling events—CCL5—primary biliary cirrhosis	0.0015	0.0061	CbGpPWpGaD
Maraviroc—CCR5—Peptide ligand-binding receptors—AGT—primary biliary cirrhosis	0.00149	0.00605	CbGpPWpGaD
Maraviroc—Mediastinal disorder—Colchicine—primary biliary cirrhosis	0.00146	0.00394	CcSEcCtD
Maraviroc—Rhinitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00146	0.00394	CcSEcCtD
Maraviroc—Rhinitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00146	0.00394	CcSEcCtD
Maraviroc—CYP3A4—Tryptophan metabolism—OGDH—primary biliary cirrhosis	0.00145	0.00589	CbGpPWpGaD
Maraviroc—Pharyngitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00144	0.0039	CcSEcCtD
Maraviroc—Pharyngitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00144	0.0039	CcSEcCtD
Maraviroc—Urinary tract disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00144	0.00388	CcSEcCtD
Maraviroc—Urinary tract disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00144	0.00388	CcSEcCtD
Maraviroc—Alopecia—Colchicine—primary biliary cirrhosis	0.00143	0.00387	CcSEcCtD
Maraviroc—Connective tissue disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00143	0.00386	CcSEcCtD
Maraviroc—Connective tissue disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00143	0.00386	CcSEcCtD
Maraviroc—Urethral disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00143	0.00385	CcSEcCtD
Maraviroc—Urethral disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00143	0.00385	CcSEcCtD
Maraviroc—Malnutrition—Colchicine—primary biliary cirrhosis	0.00141	0.00381	CcSEcCtD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—CXCL10—primary biliary cirrhosis	0.00139	0.00564	CbGpPWpGaD
Maraviroc—Eye disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00136	0.00367	CcSEcCtD
Maraviroc—Eye disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00136	0.00367	CcSEcCtD
Maraviroc—Cardiac disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00135	0.00365	CcSEcCtD
Maraviroc—Cardiac disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00135	0.00365	CcSEcCtD
Maraviroc—Angiopathy—Ursodeoxycholic acid—primary biliary cirrhosis	0.00132	0.00357	CcSEcCtD
Maraviroc—Angiopathy—Chenodeoxycholic acid—primary biliary cirrhosis	0.00132	0.00357	CcSEcCtD
Maraviroc—Mediastinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00131	0.00354	CcSEcCtD
Maraviroc—Mediastinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00131	0.00354	CcSEcCtD
Maraviroc—Anaemia—Colchicine—primary biliary cirrhosis	0.0013	0.00352	CcSEcCtD
Maraviroc—Alopecia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00129	0.00347	CcSEcCtD
Maraviroc—Alopecia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00129	0.00347	CcSEcCtD
Maraviroc—Malnutrition—Ursodeoxycholic acid—primary biliary cirrhosis	0.00127	0.00342	CcSEcCtD
Maraviroc—Malnutrition—Chenodeoxycholic acid—primary biliary cirrhosis	0.00127	0.00342	CcSEcCtD
Maraviroc—CCR5—GPCR downstream signaling—CXCR5—primary biliary cirrhosis	0.00126	0.00513	CbGpPWpGaD
Maraviroc—Leukopenia—Colchicine—primary biliary cirrhosis	0.00126	0.00341	CcSEcCtD
Maraviroc—CCR5—G alpha (i) signalling events—AGT—primary biliary cirrhosis	0.00126	0.0051	CbGpPWpGaD
Maraviroc—Flatulence—Chenodeoxycholic acid—primary biliary cirrhosis	0.00125	0.00337	CcSEcCtD
Maraviroc—Flatulence—Ursodeoxycholic acid—primary biliary cirrhosis	0.00125	0.00337	CcSEcCtD
Maraviroc—Myalgia—Colchicine—primary biliary cirrhosis	0.0012	0.00324	CcSEcCtD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—CCL5—primary biliary cirrhosis	0.00119	0.00485	CbGpPWpGaD
Maraviroc—Anaemia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00117	0.00316	CcSEcCtD
Maraviroc—Anaemia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00117	0.00316	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—CXCR5—primary biliary cirrhosis	0.00115	0.00466	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—CXCL9—primary biliary cirrhosis	0.00115	0.00466	CbGpPWpGaD
Maraviroc—Syncope—Chenodeoxycholic acid—primary biliary cirrhosis	0.00114	0.00307	CcSEcCtD
Maraviroc—Syncope—Ursodeoxycholic acid—primary biliary cirrhosis	0.00114	0.00307	CcSEcCtD
Maraviroc—Leukopenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00113	0.00306	CcSEcCtD
Maraviroc—Leukopenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00113	0.00306	CcSEcCtD
Maraviroc—Shock—Colchicine—primary biliary cirrhosis	0.00113	0.00306	CcSEcCtD
Maraviroc—Nervous system disorder—Colchicine—primary biliary cirrhosis	0.00113	0.00305	CcSEcCtD
Maraviroc—Skin disorder—Colchicine—primary biliary cirrhosis	0.00112	0.00302	CcSEcCtD
Maraviroc—Loss of consciousness—Chenodeoxycholic acid—primary biliary cirrhosis	0.00111	0.00301	CcSEcCtD
Maraviroc—Loss of consciousness—Ursodeoxycholic acid—primary biliary cirrhosis	0.00111	0.00301	CcSEcCtD
Maraviroc—Cough—Chenodeoxycholic acid—primary biliary cirrhosis	0.0011	0.00299	CcSEcCtD
Maraviroc—Cough—Ursodeoxycholic acid—primary biliary cirrhosis	0.0011	0.00299	CcSEcCtD
Maraviroc—Convulsion—Chenodeoxycholic acid—primary biliary cirrhosis	0.0011	0.00296	CcSEcCtD
Maraviroc—Convulsion—Ursodeoxycholic acid—primary biliary cirrhosis	0.0011	0.00296	CcSEcCtD
Maraviroc—Myalgia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00108	0.00291	CcSEcCtD
Maraviroc—Myalgia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00108	0.00291	CcSEcCtD
Maraviroc—Unspecified disorder of skin and subcutaneous tissue—Chenodeoxycholic acid—primary biliary cirrhosis	0.00107	0.00289	CcSEcCtD
Maraviroc—Unspecified disorder of skin and subcutaneous tissue—Ursodeoxycholic acid—primary biliary cirrhosis	0.00107	0.00289	CcSEcCtD
Maraviroc—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC2—primary biliary cirrhosis	0.00107	0.00433	CbGpPWpGaD
Maraviroc—Discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.00107	0.00288	CcSEcCtD
Maraviroc—Discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.00107	0.00288	CcSEcCtD
Maraviroc—CCR5—GPCR ligand binding—CXCL10—primary biliary cirrhosis	0.00106	0.00429	CbGpPWpGaD
Maraviroc—Musculoskeletal discomfort—Colchicine—primary biliary cirrhosis	0.00105	0.00283	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—CXCL9—primary biliary cirrhosis	0.00104	0.00423	CbGpPWpGaD
Maraviroc—Oedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.00103	0.00279	CcSEcCtD
Maraviroc—Oedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.00103	0.00279	CcSEcCtD
Maraviroc—Infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.00103	0.00277	CcSEcCtD
Maraviroc—Infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.00103	0.00277	CcSEcCtD
Maraviroc—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—primary biliary cirrhosis	0.00102	0.00413	CbGpPWpGaD
Maraviroc—Shock—Ursodeoxycholic acid—primary biliary cirrhosis	0.00102	0.00275	CcSEcCtD
Maraviroc—Shock—Chenodeoxycholic acid—primary biliary cirrhosis	0.00102	0.00275	CcSEcCtD
Maraviroc—Nervous system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00101	0.00274	CcSEcCtD
Maraviroc—Nervous system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00101	0.00274	CcSEcCtD
Maraviroc—CYP3A4—Aflatoxin activation and detoxification—GGT1—primary biliary cirrhosis	0.00101	0.0041	CbGpPWpGaD
Maraviroc—Skin disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.001	0.00271	CcSEcCtD
Maraviroc—Skin disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.001	0.00271	CcSEcCtD
Maraviroc—Decreased appetite—Colchicine—primary biliary cirrhosis	0.001	0.0027	CcSEcCtD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—AGT—primary biliary cirrhosis	0.001	0.00406	CbGpPWpGaD
Maraviroc—Gastrointestinal disorder—Colchicine—primary biliary cirrhosis	0.000993	0.00268	CcSEcCtD
Maraviroc—Fatigue—Colchicine—primary biliary cirrhosis	0.000992	0.00268	CcSEcCtD
Maraviroc—Anorexia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000985	0.00266	CcSEcCtD
Maraviroc—Anorexia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000985	0.00266	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.000941	0.00254	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.000941	0.00254	CcSEcCtD
Maraviroc—Gastrointestinal pain—Colchicine—primary biliary cirrhosis	0.00094	0.00254	CcSEcCtD
Maraviroc—Insomnia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000935	0.00253	CcSEcCtD
Maraviroc—Insomnia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000935	0.00253	CcSEcCtD
Maraviroc—Paraesthesia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000928	0.00251	CcSEcCtD
Maraviroc—Paraesthesia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000928	0.00251	CcSEcCtD
Maraviroc—CCR5—GPCR ligand binding—CCL5—primary biliary cirrhosis	0.00091	0.00369	CbGpPWpGaD
Maraviroc—Abdominal pain—Colchicine—primary biliary cirrhosis	0.000909	0.00246	CcSEcCtD
Maraviroc—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—primary biliary cirrhosis	0.0009	0.00365	CbGpPWpGaD
Maraviroc—Decreased appetite—Chenodeoxycholic acid—primary biliary cirrhosis	0.000898	0.00243	CcSEcCtD
Maraviroc—Decreased appetite—Ursodeoxycholic acid—primary biliary cirrhosis	0.000898	0.00243	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000892	0.00241	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000892	0.00241	CcSEcCtD
Maraviroc—Fatigue—Ursodeoxycholic acid—primary biliary cirrhosis	0.000891	0.00241	CcSEcCtD
Maraviroc—Fatigue—Chenodeoxycholic acid—primary biliary cirrhosis	0.000891	0.00241	CcSEcCtD
Maraviroc—Constipation—Ursodeoxycholic acid—primary biliary cirrhosis	0.000884	0.00239	CcSEcCtD
Maraviroc—Constipation—Chenodeoxycholic acid—primary biliary cirrhosis	0.000884	0.00239	CcSEcCtD
Maraviroc—Pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000884	0.00239	CcSEcCtD
Maraviroc—Pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000884	0.00239	CcSEcCtD
Maraviroc—Hypersensitivity—Colchicine—primary biliary cirrhosis	0.000847	0.00229	CcSEcCtD
Maraviroc—Gastrointestinal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000845	0.00228	CcSEcCtD
Maraviroc—Gastrointestinal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000845	0.00228	CcSEcCtD
Maraviroc—Asthenia—Colchicine—primary biliary cirrhosis	0.000825	0.00223	CcSEcCtD
Maraviroc—Abdominal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000817	0.00221	CcSEcCtD
Maraviroc—Body temperature increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000817	0.00221	CcSEcCtD
Maraviroc—Body temperature increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000817	0.00221	CcSEcCtD
Maraviroc—Abdominal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000817	0.00221	CcSEcCtD
Maraviroc—CCR5—Disease—ELMO1—primary biliary cirrhosis	0.000813	0.0033	CbGpPWpGaD
Maraviroc—Diarrhoea—Colchicine—primary biliary cirrhosis	0.000787	0.00213	CcSEcCtD
Maraviroc—Hypersensitivity—Chenodeoxycholic acid—primary biliary cirrhosis	0.000761	0.00206	CcSEcCtD
Maraviroc—Hypersensitivity—Ursodeoxycholic acid—primary biliary cirrhosis	0.000761	0.00206	CcSEcCtD
Maraviroc—CCR5—GPCR ligand binding—AGT—primary biliary cirrhosis	0.000761	0.00309	CbGpPWpGaD
Maraviroc—Asthenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000741	0.002	CcSEcCtD
Maraviroc—Asthenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000741	0.002	CcSEcCtD
Maraviroc—Vomiting—Colchicine—primary biliary cirrhosis	0.000731	0.00198	CcSEcCtD
Maraviroc—Pruritus—Ursodeoxycholic acid—primary biliary cirrhosis	0.000731	0.00198	CcSEcCtD
Maraviroc—Pruritus—Chenodeoxycholic acid—primary biliary cirrhosis	0.000731	0.00198	CcSEcCtD
Maraviroc—Rash—Colchicine—primary biliary cirrhosis	0.000725	0.00196	CcSEcCtD
Maraviroc—Dermatitis—Colchicine—primary biliary cirrhosis	0.000724	0.00196	CcSEcCtD
Maraviroc—Headache—Colchicine—primary biliary cirrhosis	0.00072	0.00195	CcSEcCtD
Maraviroc—Diarrhoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000707	0.00191	CcSEcCtD
Maraviroc—Diarrhoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000707	0.00191	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—CDH5—primary biliary cirrhosis	0.000704	0.00286	CbGpPWpGaD
Maraviroc—CCR5—Disease—NUP210—primary biliary cirrhosis	0.000697	0.00283	CbGpPWpGaD
Maraviroc—Dizziness—Ursodeoxycholic acid—primary biliary cirrhosis	0.000683	0.00185	CcSEcCtD
Maraviroc—Dizziness—Chenodeoxycholic acid—primary biliary cirrhosis	0.000683	0.00185	CcSEcCtD
Maraviroc—Nausea—Colchicine—primary biliary cirrhosis	0.000683	0.00185	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—CXCR5—primary biliary cirrhosis	0.000678	0.00275	CbGpPWpGaD
Maraviroc—Vomiting—Chenodeoxycholic acid—primary biliary cirrhosis	0.000657	0.00178	CcSEcCtD
Maraviroc—Vomiting—Ursodeoxycholic acid—primary biliary cirrhosis	0.000657	0.00178	CcSEcCtD
Maraviroc—Rash—Ursodeoxycholic acid—primary biliary cirrhosis	0.000652	0.00176	CcSEcCtD
Maraviroc—Rash—Chenodeoxycholic acid—primary biliary cirrhosis	0.000652	0.00176	CcSEcCtD
Maraviroc—Dermatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000651	0.00176	CcSEcCtD
Maraviroc—Dermatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000651	0.00176	CcSEcCtD
Maraviroc—Headache—Chenodeoxycholic acid—primary biliary cirrhosis	0.000647	0.00175	CcSEcCtD
Maraviroc—Headache—Ursodeoxycholic acid—primary biliary cirrhosis	0.000647	0.00175	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—CXCL9—primary biliary cirrhosis	0.000615	0.0025	CbGpPWpGaD
Maraviroc—Nausea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000614	0.00166	CcSEcCtD
Maraviroc—Nausea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000614	0.00166	CcSEcCtD
Maraviroc—CCR5—GPCR downstream signaling—CXCL10—primary biliary cirrhosis	0.000597	0.00243	CbGpPWpGaD
Maraviroc—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—primary biliary cirrhosis	0.000593	0.00241	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—ELMO1—primary biliary cirrhosis	0.000569	0.00231	CbGpPWpGaD
Maraviroc—CCR5—Disease—GOT2—primary biliary cirrhosis	0.000551	0.00224	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CXCL10—primary biliary cirrhosis	0.000542	0.0022	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—CCL5—primary biliary cirrhosis	0.000514	0.00209	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—MMP3—primary biliary cirrhosis	0.000495	0.00201	CbGpPWpGaD
Maraviroc—CCR5—Disease—GOT1—primary biliary cirrhosis	0.000475	0.00193	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CCL5—primary biliary cirrhosis	0.000467	0.0019	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—AGT—primary biliary cirrhosis	0.00043	0.00175	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—AGT—primary biliary cirrhosis	0.000391	0.00159	CbGpPWpGaD
Maraviroc—CCR5—Disease—HIF1A—primary biliary cirrhosis	0.000331	0.00134	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CXCL10—primary biliary cirrhosis	0.00032	0.0013	CbGpPWpGaD
Maraviroc—CCR5—Disease—NOS2—primary biliary cirrhosis	0.000301	0.00122	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—MMP3—primary biliary cirrhosis	0.000292	0.00119	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—TYK2—primary biliary cirrhosis	0.000292	0.00119	CbGpPWpGaD
Maraviroc—CCR5—Disease—CD80—primary biliary cirrhosis	0.000292	0.00119	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CCL5—primary biliary cirrhosis	0.000276	0.00112	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	0.000267	0.00109	CbGpPWpGaD
Maraviroc—CCR5—Disease—TYK2—primary biliary cirrhosis	0.000246	0.001	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—HIF1A—primary biliary cirrhosis	0.000232	0.00094	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—AGT—primary biliary cirrhosis	0.000231	0.000937	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CD80—primary biliary cirrhosis	0.000204	0.00083	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—GGT1—primary biliary cirrhosis	0.000174	0.000704	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—TYK2—primary biliary cirrhosis	0.000173	0.000701	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—MMP9—primary biliary cirrhosis	0.000136	0.000552	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—NFKB1—primary biliary cirrhosis	0.000134	0.000546	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—LBR—primary biliary cirrhosis	0.000119	0.000485	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—OGDH—primary biliary cirrhosis	8.64e-05	0.000351	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PDHX—primary biliary cirrhosis	7.7e-05	0.000312	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—DLAT—primary biliary cirrhosis	7.24e-05	0.000294	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ABCB4—primary biliary cirrhosis	7.24e-05	0.000294	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—NUP210—primary biliary cirrhosis	4.35e-05	0.000177	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ABCG2—primary biliary cirrhosis	4.04e-05	0.000164	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CTGF—primary biliary cirrhosis	3.47e-05	0.000141	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GOT2—primary biliary cirrhosis	3.44e-05	0.00014	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GOT1—primary biliary cirrhosis	2.97e-05	0.00012	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GGT1—primary biliary cirrhosis	2.97e-05	0.00012	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PPARGC1A—primary biliary cirrhosis	2.64e-05	0.000107	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—AGT—primary biliary cirrhosis	2.06e-05	8.35e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ALB—primary biliary cirrhosis	1.58e-05	6.41e-05	CbGpPWpGaD
